Gene name: PKLR
Protein name: Pyruvate kinase PKLR
List of molecules and drugs that interact with protein P30613
| # | DrugDomain Data | PBD ligand | DrugBank Accession | PubChem | ChEMBL | Name | Drug action | Affinity data |
|---|---|---|---|---|---|---|---|---|
| 1 | P30613_1PE | 1PE | n/a | 62551 | CHEMBL1229766 | PENTAETHYLENE GLYCOL | n/a | |
| 2 | P30613_ADN | ADN | DB00640 | 60961 | CHEMBL477 | ADENOSINE | n/a | |
| 3 | P30613_EDO | EDO | n/a | 174 | CHEMBL457299 | 1,2-ETHANEDIOL | n/a | |
| 4 | P30613_FBP | FBP | DB04551 | 10267 | CHEMBL97893 | 1,6-di-O-phosphono-beta-D-fructofuranose | n/a | |
| 5 | P30613_FLC | FLC | n/a | 31348 | n/a | CITRATE ANION | n/a | |
| 6 | P30613_GOL | GOL | DB09462 | 753 | CHEMBL692 | GLYCEROL | n/a | |
| 7 | P30613_I4L | I4L | n/a | 163183383 | n/a | (2~{S})-2-[2-[4-[3,4-bis(oxidanyl)-9,10-bis(oxidanylidene)anthracen-2-yl]sulfonylpiperazin-1-yl]-2-oxidanylidene-ethyl]-2-oxidanyl-butanedioic acid | n/a | |
| 8 | P30613_K | K | n/a | 813 | CHEMBL1233793 | POTASSIUM ION | n/a | |
| 9 | P30613_MG | MG | n/a | 888 | n/a | MAGNESIUM ION | n/a | |
| 10 | P30613_MN | MN | n/a | 27854 | n/a | MANGANESE (II) ION | n/a | |
| 11 | P30613_NA | NA | n/a | 923 | n/a | SODIUM ION | n/a | |
| 12 | P30613_O7F | O7F | n/a | 167713139 | CHEMBL5427010 | 4-[4-(3-aminobenzene-1-sulfonyl)piperazine-1-sulfonyl]benzene-1,2-diol | n/a | |
| 13 | P30613_O7X | O7X | n/a | 167713133 | CHEMBL5434266 | (1P)-3',4,4',5-tetrahydroxy-N-{[4-(3-hydroxybenzene-1-sulfonyl)phenyl]methyl}[1,1'-biphenyl]-2-sulfonamide | n/a | |
| 14 | P30613_O88 | O88 | n/a | 167713128 | CHEMBL5435675 | N-{[4-(3,4-dihydroxybenzene-1-sulfonyl)phenyl]methyl}-3,4-dihydroxybenzene-1-sulfonamide | n/a | |
| 15 | P30613_O8F | O8F | n/a | 167713132 | CHEMBL5434674 | (1P)-N-{[4-(3,4-dihydroxybenzene-1-sulfonyl)phenyl]methyl}-3',4,4',5-tetrahydroxy[1,1'-biphenyl]-2-sulfonamide | n/a | |
| 16 | P30613_O8O | O8O | n/a | 167713136 | CHEMBL5440938 | (10aP)-6-{[4-(3,4-dihydroxybenzene-1-sulfonyl)phenyl]methyl}-2,3,8,9-tetrahydroxy-5lambda~6~-dibenzo[c,e][1,2]thiazine-5,5(6H)-dione | n/a | |
| 17 | P30613_O8X | O8X | n/a | 167713131 | CHEMBL5424659 | 3,4-dihydroxy-N-{2-[4-(3-hydroxybenzene-1-sulfonyl)phenyl]ethyl}benzene-1-sulfonamide | n/a | |
| 18 | P30613_O99 | O99 | n/a | 167713130 | CHEMBL5425855 | 3,4-dihydroxy-N-{[4-(3-hydroxybenzene-1-sulfonyl)phenyl]methyl}benzene-1-sulfonamide | n/a | |
| 19 | P30613_O9I | O9I | n/a | 167713134 | CHEMBL5408421 | N-{[4-(3,4-dihydroxybenzene-1-sulfonyl)phenyl]methyl}-4,4',5-trihydroxy[1,1'-biphenyl]-2-sulfonamide | n/a | |
| 20 | P30613_O9R | O9R | n/a | 167713135 | CHEMBL5415497 | 4,4',5-trihydroxy-N-{[4-(3-hydroxybenzene-1-sulfonyl)phenyl]methyl}[1,1'-biphenyl]-2-sulfonamide | n/a | |
| 21 | P30613_OA0 | OA0 | n/a | 167713127 | n/a | (10aM)-3,8,9-trihydroxy-6H-6lambda~6~-dibenzo[c,e][1,2]oxathiine-6,6-dione | n/a | |
| 22 | P30613_OAT | OAT | n/a | 167713138 | CHEMBL5411883 | N-{[4-(3,4-dihydroxybenzene-1-sulfonyl)phenyl]methyl}-N-(3,4-dihydroxyphenyl)-3,4-dihydroxybenzene-1-sulfonamide | n/a | |
| 23 | P30613_OB0 | OB0 | n/a | 167713140 | CHEMBL5407560 | 4-[4-(4-aminobenzene-1-sulfonyl)piperazine-1-sulfonyl]benzene-1,2-diol | n/a | |
| 24 | P30613_OCU | OCU | n/a | 167713141 | CHEMBL5430699 | (1M)-6-[4-(3-aminobenzene-1-sulfonyl)piperazine-1-sulfonyl][1,1'-biphenyl]-3,3',4,4'-tetrol | n/a | |
| 25 | P30613_OD5 | OD5 | n/a | 19914437 | n/a | 4,4'-sulfonyldi(benzene-1,2-diol) | n/a | |
| 26 | P30613_OD9 | OD9 | n/a | 167713144 | CHEMBL5439911 | (1M)-N-({4-[(3,4-dihydroxyphenyl)methyl]phenyl}methyl)-3',4,4',5-tetrahydroxy[1,1'-biphenyl]-2-sulfonamide | n/a | |
| 27 | P30613_ODL | ODL | n/a | 167713143 | CHEMBL5410432 | N-({4-[(3,4-dihydroxyphenyl)methyl]phenyl}methyl)benzenesulfonamide | n/a | |
| 28 | P30613_OE0 | OE0 | n/a | 167713142 | CHEMBL5412990 | N-({4-[(3,4-dihydroxyphenyl)methyl]phenyl}methyl)-3,4-dihydroxybenzene-1-sulfonamide | n/a | |
| 29 | P30613_OXD | OXD | DB03902 | 971;3819775;18676629; | CHEMBL146755 | OXALIC ACID | n/a | |
| 30 | P30613_OXL | OXL | n/a | 71081 | n/a | OXALATE ION | n/a | |
| 31 | P30613_PEG | PEG | n/a | 8117 | CHEMBL1235226 | DI(HYDROXYETHYL)ETHER | n/a | |
| 32 | P30613_PEP | PEP | DB01819 | 1005;58114173;59658623; | CHEMBL1235228 | PHOSPHOENOLPYRUVATE | n/a | |
| 33 | P30613_PGA | PGA | DB02726 | 529 | CHEMBL47181 | 2-PHOSPHOGLYCOLIC ACID | n/a | |
| 34 | P30613_Y0T | Y0T | n/a | 167713129 | CHEMBL5412833 | N-{2-[4-(3,4-dihydroxybenzene-1-sulfonyl)phenyl]ethyl}-3,4-dihydroxybenzene-1-sulfonamide | n/a | |
| 35 | P30613_Y3Z | Y3Z | n/a | 167713137 | CHEMBL5415181 | (10aM)-6-{2-[4-(3,4-dihydroxybenzene-1-sulfonyl)phenyl]ethyl}-2,3,8,9-tetrahydroxy-5lambda~6~-dibenzo[c,e][1,2]thiazine-5,5(6H)-dione | n/a | |
| 36 | P30613_PYR | PYR | DB00119 | 1060 | CHEMBL1162144 | Pyruvic acid | n/a | |
| 37 | P30613_DB16236 | n/a | DB16236 | n/a | n/a | Mitapivat | activator |